Insights On Partnering

31. Enhancing Investigator Training And Communication During COVID-19 6/26/2024

    Centralizing all trial-related information, enabling seamless interaction and global team coordination through Scout Academy.

32. Successful Implementation Of A Drug-Device Combination Submission 11/21/2025

    Projects including both drug and device components require strategic planning for smooth initiation. Regulatory considerations are the key to success.

33. The Path Forward In Oncology Trials 9/10/2025

    A comprehensive site support model is crucial for navigating the complexities of modern oncology trials and accelerating drug development.

34. Making The Lives Of Patients And Research Sites Easier 5/14/2025

    Most clinical trials overlook one crucial factor: giving sites and patients a voice in how studies are run. That’s starting to change—and the impact is significant.

35. A Path To Fixing The Severe Mental Illness Care Access Gap 8/16/2024

    By breaking down research access barriers, our approach not only enhances trial participation but also promises to improve mental healthcare outcomes for patients with SMI.

36. Muscular Dystrophy: Multi-National And Multi-Site Trials 10/15/2024

    Learn about the success ReveraGen found when expanding their partnership with Novotech to a larger phase 2b trial (VBP15-004) in Duchenne Muscular Dystrophy (DMD).

37. Top 5 Challenges In Psoriasis Trials (And How To Overcome Them) 10/15/2025

    Psoriasis trials face recruitment, endpoint, regulatory, and operational challenges. Identifying common hurdles early helps sponsors streamline processes, avoid setbacks, and prevent costly delays.

38. Endometrial Cancer — Global Clinical Trial Landscape (2024) 5/17/2024

    Enhance your knowledge of the latest advancements in endometrial cancer research with this CRO disease report, featuring new treatments, clinical trials, and future innovations in care.

39. Innovation Under Pressure: Navigating Clinical Trials Amid a Pandemic 7/23/2024

    How do you complete a Phase 2b rheumatology study in three countries despite global lockdowns? Palleos cracked the code, achieving recruitment targets and regulatory approvals against all odds.

40. The Rescue Option: Course Correcting Struggling Clinical Trials 4/14/2025

    The willingness to seek expert support from Rescue CROs when clinical trials face critical challenges is not a sign of weakness but a demonstration of accountability and commitment to excellence.